List of Excipients in Branded Drug COLGATE TOTAL ADVANCED WHITENING
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Colgate-Palmolive Company | COLGATE TOTAL ADVANCED WHITENING | sodium fluoride and triclosan | 35000-354 | BUTYL ESTER OF METHYL VINYL ETHER/MALEIC ANHYDRIDE COPOLYMER | |
| Colgate-Palmolive Company | COLGATE TOTAL ADVANCED WHITENING | sodium fluoride and triclosan | 35000-354 | CARBOXYMETHYLCELLULOSE SODIUM | |
| Colgate-Palmolive Company | COLGATE TOTAL ADVANCED WHITENING | sodium fluoride and triclosan | 35000-354 | CARRAGEENAN | |
| Colgate-Palmolive Company | COLGATE TOTAL ADVANCED WHITENING | sodium fluoride and triclosan | 35000-354 | D&C YELLOW NO. 10 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Colgate Total Advanced Whitening Excipient Strategy and Commercial Opportunities
Colgate Total Advanced Whitening is a U.S. over-the-counter anticaries toothpaste, not a conventional prescription pharmaceutical. Its commercial value comes from combining sodium fluoride with an abrasive whitening system, surfactants, humectants, rheology modifiers, flavor, and appearance-control ingredients. The strongest opportunities are in low-abrasion whitening, sensitive-teeth positioning, premium delivery formats, sustainability, and regional reformulation. The product is generally governed by the FDA anticaries monograph rather than an NDA-based Orange Book patent framework.[1][2]
What active ingredient and excipients are used in Colgate Total Advanced Whitening?
The U.S. product uses sodium fluoride as its anticaries active ingredient at approximately 0.24% sodium fluoride, equivalent to 0.15% fluoride ion.[2] The excipient system is designed to deliver four functions:
- Remove or reduce extrinsic stains.
- Maintain fluoride availability during storage and brushing.
- Produce a stable, extrudable gel or paste.
- Provide acceptable taste, foaming, mouthfeel, and appearance.
Public product labels identify ingredient classes including hydrated silica, humectants, water, surfactants, cellulose-based or gum-based thickeners, flavor components, sweeteners, pH adjusters, and opacifying or color ingredients. Colgate states that formulas and ingredient lists can vary by country and may change over time.[2][3]
Representative excipient functions
| Ingredient class | Typical examples | Commercial or technical role |
|---|---|---|
| Abrasive | Hydrated silica | Removes surface stains and creates whitening claims |
| Humectant | Sorbitol, glycerin | Prevents drying and controls mouthfeel |
| Solvent | Purified water | Dissolves or disperses ingredients |
| Surfactant | Sodium lauryl sulfate, amphoteric surfactants | Foam, wetting, and soil dispersion |
| Binder | Cellulose gum, xanthan gum, carrageenan | Controls viscosity and prevents phase separation |
| Flavor | Peppermint, spearmint, cooling agents | Drives repeat use and sensory acceptance |
| Sweetener | Sodium saccharin or similar agents | Masks bitterness and improves taste |
| pH adjuster | Sodium hydroxide or other alkaline agents | Stabilizes fluoride and controls flavor |
| Opacifier or pigment | Titanium dioxide, mica, approved colorants | Creates visual whitening and product identity |
| Preservative system | Formula-dependent | Controls microbial risk, particularly in water-containing products |
The exact commercial formula should not be inferred solely from an online retailer listing. The authoritative reference is the current package Drug Facts panel and ingredient declaration for the relevant market and stock-keeping unit.
How does the excipient system create the whitening claim?
Colgate Total Advanced Whitening appears to rely primarily on physical removal and optical masking of extrinsic stains rather than a peroxide bleaching mechanism. Hydrated silica is the central excipient for this positioning.
Hydrated silica as the main whitening platform
Hydrated silica can be engineered across a range of particle sizes, structures, oil absorption values, and abrasivity. A formulation company can tune the silica system to balance:
- Stain removal.
- Enamel safety.
- Cleaning performance.
- Gloss and polish.
- Viscosity.
- Foaming compatibility.
- Flavor release.
- Tube extrusion.
A high-abrasivity system may improve rapid stain removal but can increase consumer concern about enamel wear, dentin wear, and sensitivity. A low-abrasivity system may support daily-use and sensitive-teeth claims but require stronger surfactant, polymer, or optical technologies to maintain perceived whitening.
Optical whitening and appearance control
Some whitening toothpastes use blue or blue-violet pigments, mica, titanium dioxide, or related optical materials to create an immediate visual contrast. These ingredients can increase the perception of tooth brightness without changing intrinsic tooth color.
The commercial opportunity is to separate the product into two claims:
- Immediate visual whitening through optical deposition or reflection.
- Progressive stain reduction through controlled silica abrasion.
That combination can support premium pricing while reducing dependence on peroxide, which may create taste, sensitivity, stability, or regulatory complications.
What excipient strategy best supports a next-generation version?
A next-generation formulation should focus on controlled abrasivity, fluoride compatibility, low-irritation surfactants, and differentiated sensory performance.
1. Controlled-abrasivity silica
The most defensible technical improvement is a multimodal silica system. One silica fraction can provide cleaning and stain removal, while a finer fraction improves polish and dispersion. The development target should be a narrow performance window that delivers visible stain removal without materially increasing dentin or enamel wear.
Useful claim-support data would include:
- Relative dentin abrasivity.
- Relative enamel abrasivity.
- Stain removal after standardized brushing cycles.
- Gloss or reflectance change.
- Particle-size distribution.
- Compatibility with fluoride assay methods.
- Stability after accelerated aging.
2. Low-irritation surfactant replacement
Sodium lauryl sulfate is effective for foaming and wetting but can be commercially limiting for consumers seeking sulfate-free or low-irritation products. Alternatives include cocamidopropyl betaine, sodium methyl cocoyl taurate, sodium cocoyl glutamate, and related mild surfactants.
The principal development risk is that replacing sodium lauryl sulfate can reduce foam, alter flavor release, increase viscosity instability, or affect preservative performance. A mild-surfactant product should therefore be marketed around a coherent consumer proposition, such as:
- Low-foam whitening.
- Dry-mouth compatibility.
- Sensitive-mouth use.
- Premium clean-label positioning.
- Reduced oral irritation.
3. Fluoride-compatible rheology
Cellulose gums and natural gums can bind water, influence fluoride mobility, and affect the release profile during brushing. A better rheology platform could use a polymer blend that preserves:
- Fluoride assay compliance.
- Long-term viscosity.
- Tube stability.
- Flavor dispersion.
- Uniform abrasive suspension.
- Rapid mouth dispersion.
The technical objective is not maximum viscosity. It is predictable extrusion, stable suspension, and fast dilution in saliva.
4. Humectant optimization
Sorbitol and glycerin provide moisture retention and smooth mouthfeel but can influence sweetness, tackiness, and paste structure. A revised humectant system could combine sorbitol with lower levels of glycerin or use alternative polyols to improve:
- Non-tacky mouthfeel.
- Freeze-thaw stability.
- Tube extrusion.
- Flavor persistence.
- Reduced water activity.
Humectant selection also affects sustainability claims because the source, processing, and certification of polyols may become part of the product’s marketing platform.
5. Flavor and cooling system
Flavor is a major repeat-purchase driver. Whitening products often need stronger flavor to offset silica mouthfeel, surfactant bitterness, and alkaline notes. Commercial opportunities include:
- Long-lasting mint.
- Lower-intensity mint for sensitive users.
- Freshness without high menthol.
- Flavor systems with reduced allergen disclosure burden.
- Regional flavor variants.
Flavor encapsulation or controlled-release flavor systems could create a technical distinction, although the value depends on whether the consumer perceives a meaningful freshness benefit.
What formulation patents could protect a competing or improved product?
The strongest formulation patents would protect a defined combination of ingredients and performance parameters rather than generic use of toothpaste excipients.
Potential patent claim areas
| Patent area | Example claim focus | Relative strength |
|---|---|---|
| Whitening abrasive | Specific silica blend, particle size, abrasivity, and stain-removal result | Medium to high if narrowly defined and reproducible |
| Optical whitening | Pigment or particle combination that produces immediate reflectance improvement | Medium |
| Fluoride delivery | Polymer and humectant system that improves fluoride availability or stability | Medium to high |
| Low-irritation surfactant system | Specific surfactant blend with foam and oral-tolerance performance | Medium |
| Sensitivity and whitening | Whitening abrasive combined with potassium nitrate, arginine, or another desensitizing agent | Medium |
| Flavor delivery | Encapsulated flavor or controlled-release cooling system | Low to medium |
| Manufacturing process | Mixing order, hydration sequence, deaeration, or dispersion process | Medium |
| Packaging | Tube or closure that improves stability or dose control | Low to medium |
A broad claim to “a toothpaste containing hydrated silica and sodium fluoride” would face substantial prior-art exposure. More defensible claims would combine compositional limitations with measurable performance, such as a specified abrasivity range, stain-removal threshold, fluoride stability level, or optical reflectance change.
How strong is the patent estate for Colgate Total Advanced Whitening?
The product’s commercial protection is likely based on a mixture of:
- Brand recognition.
- Trademark rights.
- Trade dress.
- Manufacturing know-how.
- Supplier relationships.
- Formulation confidentiality.
- Regulatory compliance.
- Potentially narrow formulation or process patents.
A public product name does not establish that a current, enforceable patent covers the marketed toothpaste. Patent scope must be assessed through an independent search of Colgate-Palmolive filings, assignment records, prosecution histories, and family members in the United States, Europe, China, Japan, and other relevant markets. The product label alone cannot identify active patent claims.
What is the Orange Book status of Colgate Total Advanced Whitening?
Colgate Total Advanced Whitening is generally not an Orange Book-listed product in the same manner as an NDA-approved prescription drug. FDA’s Orange Book primarily identifies approved drug products approved through NDAs and ANDAs, together with listed patents and exclusivity information.[4]
For an OTC toothpaste marketed under the anticaries monograph, the relevant regulatory framework is the FDA OTC monograph for anticaries drug products, codified at 21 C.F.R. Part 355.[1] The product’s regulatory position is therefore more closely tied to:
- Monograph-compliant active ingredients.
- Permitted concentrations.
- Required labeling.
- Manufacturing controls.
- Drug facts requirements.
- Facility and product compliance.
Are Paragraph IV challenges relevant?
A conventional Paragraph IV challenge is generally not the primary market-entry pathway for a monograph-compliant OTC toothpaste. Paragraph IV certifications relate to patents listed for approved reference drugs in the Orange Book under the ANDA framework.[4][5]
A competitor seeking to sell a similar toothpaste would typically evaluate:
- Whether the formulation falls within the OTC monograph.
- Whether trademark or trade dress rights are implicated.
- Whether a formulation, manufacturing, or use patent is enforceable.
- Whether the labeling creates a false or unsupported claim.
- Whether the product complies with FDA quality and registration requirements.
When does Colgate Total Advanced Whitening lose exclusivity?
There is no single prescription-style exclusivity expiration date for the branded toothpaste. Regulatory market access may remain available to competitors as soon as they can lawfully market a compliant competing product, subject to formulation, manufacturing, trademark, advertising, and distribution constraints.
The brand’s practical exclusivity is therefore commercial rather than a fixed statutory patent term. Key barriers include:
| Barrier | Effect on competitor |
|---|---|
| Trademark | Limits use of Colgate and Total branding |
| Trade dress | May restrict confusingly similar packaging |
| Formulation know-how | Raises development and scale-up costs |
| Retail placement | Can delay shelf access |
| Consumer loyalty | Raises marketing cost |
| Supplier qualification | Limits rapid access to specialty silica or optical ingredients |
| Claim substantiation | Requires clinical or instrumental support for whitening claims |
| Manufacturing scale | Affects cost and fill-rate competitiveness |
What generic entry risks exist for Colgate Total Advanced Whitening?
The product faces relatively low regulatory entry barriers compared with prescription drugs, but competitors still face meaningful commercial and technical risks.
Low-risk entry scenario
A private-label or branded competitor can enter with:
- Sodium fluoride at a monograph-compliant concentration.
- Hydrated silica as the whitening abrasive.
- Conventional humectants and binders.
- Independent branding.
- Compliant anticaries and whitening claims.
This scenario creates price pressure, especially through mass retailers, club stores, e-commerce, and dental-office channels.
Moderate-risk entry scenario
A competitor differentiates through:
- Sulfate-free formulation.
- Sensitive-teeth compatibility.
- Higher perceived whitening.
- Premium packaging.
- Natural or sustainable ingredients.
- Low-foam sensory profile.
This approach requires more development and consumer testing but can avoid direct price competition.
High-risk technical entry scenario
A competitor seeks to match the complete consumer experience, including:
- Immediate optical whitening.
- High stain removal.
- Low abrasivity.
- Strong foam.
- Stable fluoride.
- Long-lasting flavor.
- Premium texture.
- Long shelf life.
The formulation challenge is the simultaneous optimization of these attributes. Improving one often reduces another.
What commercial opportunities exist for excipient suppliers?
Excipient suppliers can target Colgate-Palmolive and competing oral-care manufacturers through performance-based ingredient platforms rather than commodity sales.
High-value opportunity areas
Specialty hydrated silica. Suppliers can offer silica with defined abrasivity, particle morphology, dispersion, and polishing performance.
Optical effect materials. Blue pigments, mica systems, and other approved visual technologies can support instant-whitening claims.
Mild surfactants. Sulfate-free and low-irritation systems can support premium and sensitive-mouth products.
Fluoride-compatible polymers. Suppliers can develop binders that maintain viscosity without reducing measurable fluoride availability.
Natural-origin rheology modifiers. Cellulose, alginate, carrageenan, and gum systems can support natural-positioned products, although supply consistency and microbial control remain important.
Flavor encapsulation. Controlled-release systems can improve freshness duration and mask formulation bitterness.
Sustainable excipients. Bio-based humectants, responsibly sourced silica, low-carbon manufacturing, and recyclable packaging can support procurement and retail requirements.
How does Colgate Total Advanced Whitening compare with competing toothpaste platforms?
| Platform | Primary whitening mechanism | Key excipient opportunity | Main limitation |
|---|---|---|---|
| Colgate Total Advanced Whitening | Abrasive and possibly optical stain management | Better silica performance with lower abrasivity | Limited intrinsic bleaching |
| Peroxide whitening toothpaste | Chemical oxidation plus cleaning | Stabilized peroxide delivery | Sensitivity, flavor, stability |
| Sensitive whitening toothpaste | Mild abrasive plus desensitizer | Dual whitening and sensitivity system | Lower immediate cleaning intensity |
| Charcoal toothpaste | Adsorptive and visual positioning | Controlled charcoal dispersion | Evidence and fluoride compatibility concerns |
| Premium optical toothpaste | Pigment or optical particle deposition | Immediate reflectance improvement | Temporary visual effect |
| Natural toothpaste | Alternative abrasives and surfactants | Natural-origin, fluoride-compatible systems | Taste, preservation, and performance tradeoffs |
What litigation and licensing issues affect the product?
The most likely disputes would concern formulation patents, whitening substantiation, trademark infringement, trade dress, false advertising, and supplier confidentiality. A product-specific litigation conclusion cannot be made from the brand name alone.
Licensing opportunities could involve:
- Exclusive silica technologies.
- Optical whitening particles.
- Desensitizing actives.
- Flavor encapsulation.
- Sustainable surfactants.
- Proprietary tube or dispensing systems.
- Clinical claim substantiation packages.
For Colgate-Palmolive, licensing can reduce development time if the technology supplies both a protected composition and a validated consumer benefit. For an excipient supplier, the preferred structure would combine supply rights, minimum purchase commitments, field-of-use restrictions, and ownership rules for formulation improvements.
What geographic opportunities exist for the formulation platform?
The United States, European Union, China, India, Japan, and Latin America can require different labeling, ingredient permissions, claim standards, and fluoride rules. A single global formula may therefore be commercially inefficient.
Regional strategy
- United States: Focus on anticaries monograph compliance, whitening substantiation, and mass-retail economics.
- European Union: Review cosmetic and oral-care rules, fluoride labeling, colorant permissions, and claims substantiation.
- China: Assess toothpaste filing or registration requirements, local standards, and ingredient acceptance.
- India: Optimize price, flavor intensity, pack size, and distribution economics.
- Japan: Consider local product classification, consumer preference for lower-foam products, and sensitivity positioning.
- Latin America: Address flavor preferences, price tiers, and country-specific regulatory filings.
Geographic patent protection should follow the commercial value of the excipient platform. Filing in every jurisdiction is unlikely to be efficient unless the invention covers a high-volume ingredient system with meaningful freedom-to-operate value.
Key Takeaways
- Colgate Total Advanced Whitening is an OTC anticaries toothpaste, not a conventional prescription drug.
- Sodium fluoride is the active ingredient; hydrated silica is the central whitening excipient.
- The main technical challenge is balancing stain removal, low abrasivity, fluoride stability, foam, flavor, and texture.
- The strongest commercial opportunities are specialty silica, mild surfactants, fluoride-compatible polymers, optical whitening systems, and sustainable excipients.
- Orange Book listings and Paragraph IV challenges are generally not the primary exclusivity framework for this monograph-based product.
- Brand, trade dress, formulation know-how, manufacturing scale, and retail access may matter more than a single product patent.
- A defensible patent strategy should claim defined compositions and measurable performance rather than generic toothpaste ingredients.
- Regional commercialization requires separate review of fluoride rules, claims, colorants, labeling, and product classification.
FAQs
Does Colgate Total Advanced Whitening contain hydrogen peroxide?
The publicly marketed U.S. formula is positioned primarily around sodium fluoride and silica-based stain removal. It should not be treated as equivalent to a peroxide bleaching product unless the current package label expressly identifies peroxide.
Is hydrated silica safe for daily whitening toothpaste use?
Hydrated silica is widely used in toothpaste, but its suitability depends on particle characteristics, total abrasivity, brushing force, brush design, and frequency of use. Formulators should evaluate standardized enamel and dentin wear data.
Can a competitor patent a fluoride whitening toothpaste?
Yes, but broad claims are vulnerable to prior art. Stronger patents generally require specific abrasive combinations, particle properties, polymer systems, optical materials, or demonstrated performance results.
Is Colgate Total Advanced Whitening a generic drug?
No. It is a branded OTC toothpaste containing an anticaries drug active. Competitors may market products under the OTC monograph if they satisfy applicable FDA requirements, but they cannot use Colgate trademarks or confusingly similar trade dress.
What is the most attractive excipient opportunity in whitening toothpaste?
Specialty hydrated silica has the clearest direct connection to whitening performance. The most differentiated opportunity is a silica system that delivers high stain removal and polish with low enamel and dentin abrasivity.
References
-
U.S. Food and Drug Administration. (2024). 21 C.F.R. Part 355: Anticaries drug products for over-the-counter human use. Electronic Code of Federal Regulations.
-
Colgate-Palmolive Company. (2024). Colgate Total Advanced Whitening: Product information and ingredients. Colgate.
-
Colgate-Palmolive Company. (2024). Toothpaste ingredients and oral-care product information. Colgate.
-
U.S. Food and Drug Administration. (2024). Approved drug products with therapeutic equivalence evaluations. Center for Drug Evaluation and Research.
-
U.S. Food and Drug Administration. (2024). Abbreviated new drug application submissions and patent certifications. Center for Drug Evaluation and Research.
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
Visit the Subscription Options page for details on plans and pricing.
ISSN: 2162-2639

Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Access the Complete Database
Deeper Knowledge, Faster
- Uncover prior art in expired and abandoned patents
- Obtain formulation and manufacturing information
- Drug patents in 130+ countries